Medline Shares Rise 16% After Company Raises Outlook
Medline said it now expects organic sales growth of 10% to 10.5%, up from its prior outlook, following higher third-quarter sales. Shares rose 16% to $39.67 on Wednesday and remained down 5.6% for the year.
By Katherine HamiltonMedline shares climbed after the company raised its outlook following higher third-quarter sales.The stock rose 16% to $39.67 on Wednesday, leaving shares down 5.6% this year.The medical supplies company said it now expects organic sales to grow 10% to 10.5%, up from its prior…